If finalized, it would formally close their pathway to compound semaglutide and tirzepatide from bulk substances
However, GLP-1 drugs have surged in popularity due to their ability to support major weight loss and reduce risks for chronic conditions, including heart disease
In November of 2025, however, the drug's manufacturer Novo Nordisk announced a more affordable option: uninsured patients (or those who have insurance that doesn't cover Wegovy) can access all dose strengths of Wegovy injections at a reduced cash price of $349 per month via Novo Nordisk's direct-to-consumer online pharmacy, NovoCare
In 2024, a study was conducted that aimed to analyze the nutrient intakes of a carnivore diet
As you age, youre more at risk for nutritional deficiencies due to shifts in appetite (with or without GLP-1s), changes in daily activity, hormonal changes, and more
To view a copy of this licence, visit About this article Cite this article Ahmad, N., Lesa, K.N., Ikawati, Z